세계의 줄기세포 제대혈 시장 보고서(2025년)

Umbilical cord blood stem cells are a unique type of cells obtained from the blood left in the umbilical cord and placenta following childbirth. This blood is a rich source of hematopoietic stem cells (HSCs), which can transform into various blood cells, including red blood cells, white blood cells, and platelets. These stem cells are widely used in medical treatments such as bone marrow transplants for individuals suffering from blood-related conditions like leukemia, lymphoma, and specific genetic disorders.

The key components of umbilical cord blood stem cells include both cord blood stem cells and cord tissue stem cells. Cord blood stem cells, which are hematopoietic in nature, are collected from a newborn's umbilical cord and are utilized in treating blood and immune-related disorders. The technologies involved encompass cryopreservation, stem cell expansion, and cell separation. Storage options are divided among public cord blood banks, private cord blood banks, and hybrid models. The primary uses of stem cell umbilical cord blood span across hematologic diseases, metabolic disorders, immune deficiencies, neurological conditions, and more, catering to end-users such as hospitals, research centers, biotech firms, and others.

The stem cell umbilical cord blood market research report is one of a series of new reports from The Business Research Company that provides stem cell umbilical cord blood market statistics, including stem cell umbilical cord blood industry global market size, regional shares, competitors with a stem cell umbilical cord blood market share, detailed stem cell umbilical cord blood market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell umbilical cord blood industry. This stem cell umbilical cord blood market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The stem cell umbilical cord blood market size has grown rapidly in recent years. It will grow from $6.77 billion in 2024 to $7.98 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. This growth during the historical period can be credited to rising investments in research and development, heightened demand for private cord blood banking, a surge in clinical trial activities, a growing number of cancer cases, and an increase in fertility clinics worldwide.

The stem cell umbilical cord blood market size is expected to see rapid growth in the next few years. It will grow to $15.21 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. Factors contributing to this anticipated growth include the escalating incidence of chronic diseases, higher birth rates, growing interest in stem cell-based therapies, supportive governmental policies, and increasing emphasis on regenerative medicine. Noteworthy trends projected for this period include progress in therapeutic applications, improvements in healthcare infrastructure, innovations in cryopreservation technology, and the fusion of stem cell treatments with gene therapy advancements.

The rising childbirth rates are anticipated to drive the growth of the stem cell umbilical cord blood market in the coming years. Childbirth rates refer to the number of live births per 1,000 individuals in a population over a specific period, typically one year. The growth in childbirth rates is primarily attributed to the increased availability and affordability of fertility treatments, allowing more families to conceive. Umbilical cord blood stem cells are particularly valuable for newborns because they contain hematopoietic stem cells, which are instrumental in treating a range of blood, immune, and genetic disorders. These cells are genetically matched to the infant and may also be beneficial for siblings or other family members. For example, in April 2025, the U.S. Centers for Disease Control and Prevention reported that the number of births in the United States rose from 3,596,017 in 2023 to 3,622,673 in 2024, marking a 1% increase. As a result, the growing childbirth rates are significantly contributing to the expansion of the stem cell umbilical cord blood market.

Leading companies in the stem cell umbilical cord blood market are concentrating on developing innovative therapies and securing approvals, such as cord blood cell therapy for treating rare genetic disorders, enhancing immune system recovery, and supporting regenerative medicine initiatives. Cord blood cell therapy involves using stem cells obtained from umbilical cord blood to treat various medical conditions by regenerating or repairing damaged blood, immune, and tissue systems. For instance, in October 2024, StemCyte, a biotechnology company based in the United States, received regenerative medicine advanced therapy designation from the U.S. Food and Drug Administration (FDA) for its hematopoietic progenitor cell cord blood therapy (HPC Cord Blood) designed to treat Long COVID-19 syndrome. This cord blood cell therapy leverages umbilical cord stem cells to aid in healing and reduce inflammation. It has demonstrated promise in treating immune-related and degenerative disorders and offers a non-invasive, ethically sourced alternative for advanced regenerative therapies.

In July 2023, Leukaemia & Myeloma Research UK, a stem cell therapies organization based in the United Kingdom, partnered with Smart Cells International to offer funded storage of cord blood stem cells. This collaboration is intended to give families a secure and efficient method for collecting and preserving umbilical cord blood stem cells for future medical applications and research purposes. Smart Cells International, also headquartered in the UK, specializes in the collection and storage of umbilical cord blood stem cells.

Major players in the stem cell umbilical cord blood market are Takeda Pharmaceutical Company Limited, Global Cord Blood Corporation, Vita 34 AG, Cordlife Group Limited, StemLife Berhad, MediPost Co. Ltd., Smart Cells International Ltd., StemCyte Inc., Celularity Inc., Next Biosciences Pty Ltd, Esperite N.V., Cryo-Cell International Inc., FamiCord Group, Cells4Life Group LLP, Cryoviva Biotech Pvt. Ltd., Americord Registry LLC, ViaCord LLC, China Cord Blood Corporation, CBR Systems Inc., Cord Blood Registry.

North America was the largest region in the stem cell umbilical cord blood market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in stem umbilical cord blood report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the stem umbilical cord blood market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The stem umbilical cord blood market consists of revenues earned by entities by providing services such as collection services, processing, testing, cryopreservation, storage, and transportation of cord blood, as well as related genetic screening and stem cell banking services. The market value includes the value of related goods sold by the service provider or included within the service offering. The stem umbilical cord blood market also includes sales of whole cord blood units, isolated stem cell products, and cord blood expansion kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Stem Cell Umbilical Cord Blood Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on stem cell umbilical cord blood market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for stem cell umbilical cord blood ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The stem cell umbilical cord blood market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Cord Blood Stem Cells; Cord Tissue Stem Cells
• 2) By Technology: Cryopreservation; Stem Cell Expansion; Cell Separation
• 3) By Storage Services: Public Cord Blood Banks; Private Cord Blood Banks; Hybrid Cord Blood Banks
• 4) By Application: Hematological Disorders; Metabolic Diseases; Immune System Disorders; Neurological Disorders; Other Applications
• 5) By End-User: Hospitals; Research Institutes; Biotechnology Companies; Other End-Users
• Subsegments:
• 1) By Cord Blood Stem Cells: Hematopoietic Stem Cells; Mesenchymal Stem Cells; Endothelial Progenitor Cells; Regulatory T Cells; Natural Killer Cells; Dendritic Cells
• 2) By Cord Tissue Stem Cells: Mesenchymal Stem Cells; Epithelial Cells; Fibroblasts; Neural Progenitor Cells
• Companies Mentioned: Takeda Pharmaceutical Company Limited; Global Cord Blood Corporation; Vita 34 AG; Cordlife Group Limited; StemLife Berhad
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Stem Cell Umbilical Cord Blood Market Characteristics

3. Stem Cell Umbilical Cord Blood Market Trends And Strategies

4. Stem Cell Umbilical Cord Blood Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Stem Cell Umbilical Cord Blood Growth Analysis And Strategic Analysis Framework

• 5.1. Global Stem Cell Umbilical Cord Blood PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Stem Cell Umbilical Cord Blood Market Growth Rate Analysis
• 5.4. Global Stem Cell Umbilical Cord Blood Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Stem Cell Umbilical Cord Blood Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Stem Cell Umbilical Cord Blood Total Addressable Market (TAM)

6. Stem Cell Umbilical Cord Blood Market Segmentation

• 6.1. Global Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cord Blood Stem Cells
• Cord Tissue Stem Cells
• 6.2. Global Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cryopreservation
• Stem Cell Expansion
• Cell Separation
• 6.3. Global Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Public Cord Blood Banks
• Private Cord Blood Banks
• Hybrid Cord Blood Banks
• 6.4. Global Stem Cell Umbilical Cord Blood Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hematological Disorders
• Metabolic Diseases
• Immune System Disorders
• Neurological Disorders
• Other Applications
• 6.5. Global Stem Cell Umbilical Cord Blood Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Research Institutes
• Biotechnology Companies
• Other End-Users
• 6.6. Global Stem Cell Umbilical Cord Blood Market, Sub-Segmentation Of Cord Blood Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hematopoietic Stem Cells
• Mesenchymal Stem Cells
• Endothelial Progenitor Cells
• Regulatory T Cells
• Natural Killer Cells
• Dendritic Cells
• 6.7. Global Stem Cell Umbilical Cord Blood Market, Sub-Segmentation Of Cord Tissue Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mesenchymal Stem Cells
• Epithelial Cells
• Fibroblasts
• Neural Progenitor Cells

7. Stem Cell Umbilical Cord Blood Market Regional And Country Analysis

• 7.1. Global Stem Cell Umbilical Cord Blood Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Stem Cell Umbilical Cord Blood Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell Umbilical Cord Blood Market

• 8.1. Asia-Pacific Stem Cell Umbilical Cord Blood Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell Umbilical Cord Blood Market

• 9.1. China Stem Cell Umbilical Cord Blood Market Overview
• 9.2. China Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell Umbilical Cord Blood Market

• 10.1. India Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell Umbilical Cord Blood Market

• 11.1. Japan Stem Cell Umbilical Cord Blood Market Overview
• 11.2. Japan Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell Umbilical Cord Blood Market

• 12.1. Australia Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell Umbilical Cord Blood Market

• 13.1. Indonesia Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell Umbilical Cord Blood Market

• 14.1. South Korea Stem Cell Umbilical Cord Blood Market Overview
• 14.2. South Korea Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell Umbilical Cord Blood Market

• 15.1. Western Europe Stem Cell Umbilical Cord Blood Market Overview
• 15.2. Western Europe Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell Umbilical Cord Blood Market

• 16.1. UK Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell Umbilical Cord Blood Market

• 17.1. Germany Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell Umbilical Cord Blood Market

• 18.1. France Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell Umbilical Cord Blood Market

• 19.1. Italy Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell Umbilical Cord Blood Market

• 20.1. Spain Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell Umbilical Cord Blood Market

• 21.1. Eastern Europe Stem Cell Umbilical Cord Blood Market Overview
• 21.2. Eastern Europe Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell Umbilical Cord Blood Market

• 22.1. Russia Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell Umbilical Cord Blood Market

• 23.1. North America Stem Cell Umbilical Cord Blood Market Overview
• 23.2. North America Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell Umbilical Cord Blood Market

• 24.1. USA Stem Cell Umbilical Cord Blood Market Overview
• 24.2. USA Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell Umbilical Cord Blood Market

• 25.1. Canada Stem Cell Umbilical Cord Blood Market Overview
• 25.2. Canada Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell Umbilical Cord Blood Market

• 26.1. South America Stem Cell Umbilical Cord Blood Market Overview
• 26.2. South America Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell Umbilical Cord Blood Market

• 27.1. Brazil Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell Umbilical Cord Blood Market

• 28.1. Middle East Stem Cell Umbilical Cord Blood Market Overview
• 28.2. Middle East Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell Umbilical Cord Blood Market

• 29.1. Africa Stem Cell Umbilical Cord Blood Market Overview
• 29.2. Africa Stem Cell Umbilical Cord Blood Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Stem Cell Umbilical Cord Blood Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Stem Cell Umbilical Cord Blood Market, Segmentation By Storage Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell Umbilical Cord Blood Market Competitive Landscape And Company Profiles

• 30.1. Stem Cell Umbilical Cord Blood Market Competitive Landscape
• 30.2. Stem Cell Umbilical Cord Blood Market Company Profiles
  • 30.2.1. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Global Cord Blood Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Vita 34 AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Cordlife Group Limited Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. StemLife Berhad Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell Umbilical Cord Blood Market Other Major And Innovative Companies

• 31.1. MediPost Co. Ltd.
• 31.2. Smart Cells International Ltd.
• 31.3. StemCyte Inc.
• 31.4. Celularity Inc.
• 31.5. Next Biosciences Pty Ltd
• 31.6. Esperite N.V.
• 31.7. Cryo-Cell International Inc.
• 31.8. FamiCord Group
• 31.9. Cells4Life Group LLP
• 31.10. Cryoviva Biotech Pvt. Ltd.
• 31.11. Americord Registry LLC
• 31.12. ViaCord LLC
• 31.13. China Cord Blood Corporation
• 31.14. CBR Systems Inc.
• 31.15. Cord Blood Registry

32. Global Stem Cell Umbilical Cord Blood Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Umbilical Cord Blood Market

34. Recent Developments In The Stem Cell Umbilical Cord Blood Market

35. Stem Cell Umbilical Cord Blood Market High Potential Countries, Segments and Strategies

• 35.1 Stem Cell Umbilical Cord Blood Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Stem Cell Umbilical Cord Blood Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Stem Cell Umbilical Cord Blood Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer